ONCOSYNE AS
926191942ActiveDeveloping cancer treatments using patient-derived 3D tumoroid models.
Oversigt
- 6
- Medarbejdere
- 4.4mio NOK
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Jarle Bruun
CEO and co-founder
Aarti Kapoor
Director, Strategic Partnerships
Peter W. Eide
CTO and co-founder
Christer Anker Andreassen
Product developer
+8 flere kontakter i Funnelfeedr
Beskrivelse
Oncosyne operates at the forefront of precision oncology, utilizing its proprietary iCAN tumoroid platform. This platform creates living, patient-derived 3D tumor models that accurately mimic the characteristics of a patient's original cancer. For the pharmaceutical industry, Oncosyne offers compreh...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
12 kontakter i FunnelfeedrJarle Bruun
CEO and co-founder
Aarti Kapoor
Director, Strategic Partnerships
Peter W. Eide
CTO and co-founder
Christer Anker Andreassen
Product developer
Andre kontakter
Øyvind Bruland
Clinical advisor
Åke Andrén-Sandberg
Clinical advisor
Tine Norman Alver
Laboratory scientist
Janne Nestvold
Business advisor
+4 flere kontakter i Funnelfeedr
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrDOMORE DIAGNOSTICS AS
9 medarbejdereDeveloping AI pathology tests for personalized cancer treatment decisions.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
OSLO SCIENCE HUB AS
Accelerating cancer treatment development through collaboration and innovation.
RAB DIAGNOSTICS AS
Developing predictive biomarkers for optimizing Antibody-Drug Conjugate therapies.
HEMISPHERIAN AS
5 medarbejdereDeveloping novel small molecule drugs targeting TET2 for aggressive cancers.
Udforsk mere
Spørgsmål om ONCOSYNE AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo